Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Pancreas (Neoplasia).php on line 2
Pancreas (Neoplasia)
LE WE PMID CA
Pancreas (Neoplasia)2101Pankreas (Neubildung)

Acinar cell carcinoma

Biliary system (Cholestasis BASKET)

Biliary system (Neoplasia)

Bone (Metastasis)

Capecitabine

Chemoprevention

Curcumin

Cystic fibrosis

Endosonography

Epigenetics

Familial adenomatous polyposis

Gemcitabine

Giant cell tumor of the pancreas

Granular cell tumor

HMGA protein family

HuR

ILT3

Interleukin24 MDA7

Intestines (Neoplasia)

KRAS

Liver (Neoplasia)

Neoplasia (Inherited)

Neoplasia (Oncolytic virus)

Neoplasia (Tumor biology and immunology)

Neuroendocrine System (Neoplasia Carcinoid)

Neuroendocrine system (Neoplasia)

Pancreas (CT)

Pancreas (Imaging)

Pancreas (Neoplasia Pancreatoblastoma)

Pancreas (Neoplasia)

Pancreas (Sonography)

Pancreatic ductal adenocarcinoma

Pancreatic sarcoma

Pancreatitis (chronic)

PAR4

Perillyl alcohol

RNA (MicroRNA)

Rubitecan

SMAD

Ultrasound (endoscopic)

Ultrasound (Toxicity and therapeutic use)

Xanthine oxidase

2008  
1
Small molecule tyrosine kinase inhibitors in pancreatic cancer.
[19707451] Biologics 2(4): 707-15 (2008)
2008  
2
Diagnostic evaluation of cystic pancreatic lesions.
[18695762] HPB (Oxford) 10(1): 63-9 (2008)
2007  
3
Cystic tumours of the pancreas.
[18345301] HPB (Oxford) 9(4): 259-66 (2007)
2008  
4
Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.
[18645105] Arch Surg 143(7): 639-46; discussion 646 (2008)
2007  
5
Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005.
[17438169] Arch Surg 142(4): 347-54 (2007)
2006  
6
Central pancreatectomy: a technique for the resection of pancreatic neck lesions.
[16549696] Arch Surg 141(3): 293-9 (2006)
2003  
7
Spectrum of cystic neoplasms of the pancreas and their surgical management.
[12799338] Arch Surg 138(6): 657-60; discussion 660-2 (2003)
2005  
8
Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment.
[16135927] Ann Surg 242(3): 413-9; discussion 419-21 (2005)
2004  
9
Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome.
[15075659] Ann Surg 239(3): 400-8 (2004)
1999  
10
Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association.
[10450728] Ann Surg 230(2): 152-61 (1999)
1997  
11
Pancreatic resection combined with intraoperative radiation therapy for pancreatic cancer.
[9242339] Ann Surg 226(1): 66-9 (1997)
1997  
12
Pancreatic mucinous ductal ectasia and intraductal papillary neoplasms. A single malignant clinicopathologic entity.
[9230804] Ann Surg 225(6): 637-44; discussion 644-6 (1997)
1997  
13
Adenocarcinoma of the ampulla of Vater. A 28-year experience.
[9193186] Ann Surg 225(5): 590-9; discussion 599-600 (1997)
1996  
14
Mucin-producing neoplasms of the pancreas. Intraductal papillary and mucinous cystic neoplasms.
[8597507] Ann Surg 223(2): 141-6 (1996)
1995  
15
Current management of pancreatic carcinoma.
[7531966] Ann Surg 221(2): 133-48 (1995)
1990  
16
Surgical palliation for pancreatic cancer. The UCLA experience.
[1695834] Ann Surg 212(2): 132-9 (1990)
1987  
17
Cystic tumors mistaken for pancreatic pseudocysts.
[3566376] Ann Surg 205(4): 393-8 (1987)
1986  
18
Collective review of small carcinomas of the pancreas.
[3942423] Ann Surg 203(1): 77-81 (1986)
1984  
19
Comparison of conventional surgical resection, radioactive implantation, and bypass procedures for exocrine carcinoma of the pancreas 1975-1980.
[6419687] Ann Surg 199(1): 1-5 (1984)
1978  
20
A clinicopathologic study of 21 cases of pancreatic cystadenocarcinoma.
[718294] Ann Surg 188(5): 679-84 (1978)
1977  
21
Carcinoma of the pancreas and periampullary region: a 41 year experience.
[603275] Ann Surg 186(6): 730-3 (1977)
2003  
22
Review article: chemotherapy for pancreatic cancer.
[14653825] Aliment Pharmacol Ther 18(11-12): 1049-69 (2003)
1998  
23
Review article: current treatment and optimal patient management in pancreatic cancer.
[9798799] Aliment Pharmacol Ther 12(10): 949-64 (1998)
1998  
24
Review article: current practice and future perspectives in detection and diagnosis of pancreatic cancer.
[9798798] Aliment Pharmacol Ther 12(10): 937-48 (1998)
2010  
25
Current and emerging therapies for the treatment of pancreatic cancer.
[20856847] Onco Targets Ther 3(-): 111-27 (2010)
2008  
26
Pancreatic cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[18456756] Ann Oncol 19 Suppl 2(-): ii25-6 (2008)
2007  
27
The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006.
[17600091] Ann Oncol 18 Suppl 7(-): vii1-vii10 (2007)
2005  
28
Multimodality approaches for pancreatic cancer.
[16282280] CA Cancer J Clin 55(6): 352-67 (2005)
2008  
29
Adjuvant therapy for pancreatic cancer: a review.
[18050292] Cancer 112(2): 243-9 (2008)
2004  
30
Rare ductal adenocarcinoma of the pancreas in patients younger than age 40 years.
[14692038] Cancer 100(1): 173-82 (2004)
2004  
31
Surgical management of early-stage pancreatic cancer.
[14749620] Cancer Control 11(1): 23-31 (2004)
2004  
32
Applications of endoscopic ultrasonography in pancreatic cancer.
[14749619] Cancer Control 11(1): 15-22 (2004)
2007  
33
Extended resection for pancreatic adenocarcinoma.
[17602057] Oncologist 12(6): 654-63 (2007)
2003  
34
The medical management of pancreatic cancer: a review.
[12697940] Oncologist 8(2): 149-60 (2003)
2006  
35
Genetics and biology of pancreatic ductal adenocarcinoma.
[16702400] Genes Dev 20(10): 1218-49 (2006)
1997  
36
Pancreatic adenocarcinoma: why and when should it be resected?
[9307737] Postgrad Med J 73(862): 469-75 (1997)
1993  
37
K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
[8342602] Am J Pathol 143(2): 545-54 (1993)
2008  
38
Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.
[18508996] Endocr Relat Cancer 15(2): 409-27 (2008)
2001  
39
Selected features of nonendocrine pancreatic cancer.
[11395922] Exp Biol Med (Maywood) 226(6): 521-37 (2001)
2005  
40
Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.
[15888770] Gut 54 Suppl 5(-): v1-16 (2005)
1991  
41
Biology of pancreatic cancer.
[1855689] Gut 32(7): 800-12 (1991)
2009  
42
Cancer of the uncinate process of the pancreas: surgical anatomy and clinicopathological features.
[20007071] Hepatobiliary Pancreat Dis Int 8(6): 569-74 (2009)
2008  
43
2002  
44
Surgical approaches for resection of pancreatic cancer: an overview.
[14607639] Hepatobiliary Pancreat Dis Int 1(1): 118-25 (2002)
2007  
45
Treatment options for hepatobiliary and pancreatic cancer.
[17493429] Mayo Clin Proc 82(5): 628-37 (2007)
2010  
46
Vascular invasion in pancreatic cancer: Imaging modalities, preoperative diagnosis and surgical management.
[20143460] World J Gastroenterol 16(7): 818-31 (2010)
2010  
47
Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer.
[20135714] World J Gastroenterol 16(6): 673-82 (2010)
2009  
48
Vitamin D for the prevention and treatment of pancreatic cancer.
[19610135] World J Gastroenterol 15(27): 3349-54 (2009)
2009  
49
Cystic neoplasms of the pancreas: a diagnostic challenge.
[19115467] World J Gastroenterol 15(1): 48-54 (2009)
2008  
50
Intraductal papillary mucinous neoplasms and other pancreatic cystic lesions.
[18494045] World J Gastroenterol 14(19): 2977-9 (2008)
2006  
51
Meta-analysis on inoperable pancreatic cancer: a comparison between gemcitabine-based combination therapy and gemcitabine alone.
[17109519] World J Gastroenterol 12(43): 6973-81 (2006)
2006  
52
Oncological problems in pancreatic cancer surgery.
[16874856] World J Gastroenterol 12(28): 4466-72 (2006)
2006  
53
Less common neoplasms of the pancreas.
[16718837] World J Gastroenterol 12(20): 3180-5 (2006)
2003  
54
State-of-the-art imaging of pancreatic neoplasms.
[14711772] Br J Radiol 76(912): 857-65 (2003)
2003  
55
Diagnosis, staging, and surveillance of pancreatic cancer.
[12704043] AJR Am J Roentgenol 180(5): 1311-23 (2003)
1988  
56
Cystic pancreatic tumors: CT and sonographic assessment.
[3055888] AJR Am J Roentgenol 151(6): 1133-8 (1988)
2007  
57
Comprehensive preoperative assessment of pancreatic adenocarcinoma with 64-section volumetric CT.
[18025509] Radiographics 27(6): 1653-66 (2007)
2006  
58
Pancreatic tumors in children: radiologic-pathologic correlation.
[16844942] Radiographics 26(4): 1211-38 (2006)
2006  
59
Multi-detector row CT of pancreatic islet cell tumors.
[16549609] Radiographics 26(2): 453-64 (2006)
2005  
60
Cystic pancreatic lesions: a simple imaging-based classification system for guiding management.
[16284129] Radiographics 25(6): 1471-84 (2005)
2005  
61
Intraductal papillary mucinous neoplasm of the pancreas: can benign lesions be differentiated from malignant lesions with multidetector CT?
[16284127] Radiographics 25(6): 1451-68; discussion 1468-70 (2005)
2005  
62
Imaging diagnosis of cystic pancreatic lesions: pseudocyst versus nonpseudocyst.
[15888617] Radiographics 25(3): 671-85 (2005)
2001  
63
Radiologic spectrum of intraductal papillary mucinous tumor of the pancreas.
[11259696] Radiographics 21(2): 323-37; discussion 337-40 (2001)
1992  
64
Cystic masses of the pancreas.
[1636033] Radiographics 12(4): 673-86 (1992)
1990  
65
From the Archives of the AFIP. Microcystic adenoma of the pancreas.
[2183300] Radiographics 10(2): 313-22 (1990)
2001  
66
MRI of pancreatic neuroendocrine tumours.
[11675319] Br J Radiol 74(886): 968-73 (2001)
2000  
67
Pancreatoblastoma: imaging findings in 10 patients and review of the literature.
[10671596] Radiology 214(2): 476-82 (2000)
1999  
68
Pancreatic carcinoma versus chronic pancreatitis: dynamic MR imaging.
[10405744] Radiology 212(1): 213-8 (1999)
2010  
69
Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations.
[20697118] Radiology 257(1): 87-96 (2010)
1996  
70
Solid and papillary epithelial neoplasm of the pancreas: imaging-pathologic correlation on 56 cases.
[8637992] Radiology 199(3): 707-11 (1996)
2010  
71
Pancreatic cancer: pathobiology, treatment options, and drug delivery.
[20198462] AAPS J 12(2): 223-32 (2010)
2010  
72
Update on familial pancreatic cancer.
[20919528] Adv Surg 44(-): 293-311 (2010)
2010  
73
Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
[20555103] Ann Oncol 21 Suppl 5(-): v55-8 (2010)
2009  
74
Pancreatic cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[19454458] Ann Oncol 20 Suppl 4(-): 37-40 (2009)
2010  
75
Complementary roles of CT and endoscopic ultrasound in evaluating a pancreatic mass.
[20308501] AJR Am J Roentgenol 194(4): 984-92 (2010)
2010  
76
Radiofrequency ablation of locally advanced pancreatic adenocarcinoma: an overview.
[20653055] World J Gastroenterol 16(28): 3478-83 (2010)
2011  
77
Molecular biology of pancreatic cancer.
[21734801] World J Gastroenterol 17(24): 2897-908 (2011)
2011  
78
Review of screening for pancreatic cancer in high risk individuals.
[21633635] World J Gastroenterol 17(19): 2365-71 (2011)
2011  
79
MicroRNAs in pancreatic ductal adenocarcinoma.
[21412491] World J Gastroenterol 17(7): 817-27 (2011)
2011  
80
Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.
[21412497] World J Gastroenterol 17(7): 867-97 (2011)
2004  
81
Management of nonfunctioning islet cell tumors.
[15188511] World J Gastroenterol 10(12): 1806-9 (2004)
2008  
82
Surgical outcome of adenosquamous carcinoma of the pancreas.
[19058301] World J Gastroenterol 14(44): 6765-70 (2008)
2007  
83
Role of endoscopic ultrasound in diagnosis and therapy of pancreatic adenocarcinoma.
[17659723] World J Gastroenterol 13(27): 3662-6 (2007)
2010  
84
Therapeutic antibodies for the treatment of pancreatic cancer.
[20563534] ScientificWorldJournal 10(-): 1107-20 (2010)
2010  
85
Pancreatic cancer: molecular, biochemical, chemopreventive, and therapeutic aspects.
[20890586] ScientificWorldJournal 10(-): 1967-70 (2010)
2010  
86
Chemoradiation in pancreatic adenocarcinoma: a literature review.
[20203172] Oncologist 15(3): 259-69 (2010)
2005  
87
Phase II trial of oral rubitecan in previously treated pancreatic cancer patients.
[15793221] Oncologist 10(3): 183-90 (2005)
2009  
88
Neuroendocrine tumors of the pancreas.
[19411317] Oncologist 14(5): 456-67 (2009)
2010  
89
Development of curcumin as an epigenetic agent.
[20597137] Cancer 116(20): 4670-6 (2010)
2007  
90
Gemcitabine-based combinations for inoperable pancreatic cancer: have we made real progress? A meta-analysis of 20 phase 3 trials.
[17577216] Cancer 110(3): 525-33 (2007)
2010  
91
The place of endoscopic ultrasound in bilio-pancreatic pathology.
[20579826] Gastroenterol Clin Biol 34(8-9): 436-45 (2010)
2006  
92
2009  
93
Survival in cystic neoplasms of the pancreas.
[19668796] Can J Gastroenterol 23(8): 537-42 (2009)
2010  
94
Neurotransmitter receptors as central regulators of pancreatic cancer.
[20146581] Future Oncol 6(2): 221-8 (2010)
2007  
95
Pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI).
[17921087] Cancer Imaging 7 Spec No A(-): S160-5 (2007)
2006  
96
Interventional endosonography for pancreatic cancer.
[16998240] JOP 7(5): 441-6 (2006)
2011  
97
Pseudopapillary tumor of the pancreas. An algorithmic approach.
[21546705] JOP 12(3): 262-5 (2011)
2011  
98
Rationale for inhibition of the hedgehog pathway paracrine loop in pancreatic adenocarcinoma.
[21206093] JOP 12(1): 1-5 (2011)
2011  
99
Pancreatic neoplasm in 2011: an update.
[21737886] JOP 12(4): 316-21 (2011)
2010  
100
Molecular and clinical markers of pancreas cancer.
[21068484] JOP 11(6): 536-44 (2010)
2010  
101
Options for the treatment of gemcitabine-resistant advanced pancreatic cancer.
[20208317] JOP 11(2): 113-23 (2010)
2010  
102
Identification and screening of individuals at increased risk for pancreatic cancer with emphasis on known environmental and genetic factors and hereditary syndromes.
[20442513] JOP 11(3): 203-12 (2010)
2007  
103
Antiproteases in preventing the invasive potential of pancreatic cancer cells.
[17625307] JOP 8(4 Suppl): 501-8 (2007)
2007  
104
Pancreas cancer and the role of soluble immunoglobulin-like transcript 3 (ILT3).
[17993722] JOP 8(6): 697-703 (2007)
2009  
105
Role of anticoagulation in the management of pancreatic cancer.
[19287098] JOP 10(2): 82-7 (2009)
2009  
106
Pancreatic cancer: translating lessons from mouse models.
[19287100] JOP 10(2): 98-103 (2009)
2009  
107
Advancements in the management of pancreatic cancer.
[19287102] JOP 10(2): 109-17 (2009)
2009  
108
Therapeutic tools in pancreatic cancer.
[19287103] JOP 10(2): 118-22 (2009)
2009  
109
Frantz's tumor (solid pseudopapillary tumor) of the pancreas. A case report.
[19287121] JOP 10(2): 209-11 (2009)
2007  
110
2005  
111
Chemoradiation for ductal pancreatic carcinoma: principles of combining chemotherapy with radiation, definition of target volume and radiation dose.
[15883472] JOP 6(3): 216-30 (2005)
2005  
112
Management of the mucin filled bile duct. A complication of intraductal papillary mucinous tumor of the pancreas.
[15883476] JOP 6(3): 255-9 (2005)
2008  
113
Pancreatic carcinosarcoma. Case report of multimodal therapy and review of the literature.
[18182744] JOP 9(1): 50-5 (2008)
2008  
114
The pancreas in familial adenomatous polyposis.
[18182737] JOP 9(1): 9-18 (2008)
2009  
115
Cystic neoplasms of the pancreas: current diagnostic modalities and management.
[19347080] Ann Acad Med Singapore 38(3): 251-9 (2009)
2007  
116
Chronic pancreatitis, pseudotumors and other tumor-like lesions.
[17486047] Mod Pathol 20 Suppl 1(-): S113-31 (2007)
2007  
117
Nonductal neoplasms of the pancreas.
[17486055] Mod Pathol 20 Suppl 1(-): S94-112 (2007)
2011  
118
Looking to the future: biomarkers in the management of pancreatic adenocarcinoma.
[22016635] Int J Mol Sci 12(9): 5895-907 (2011)
2010  
119
Intraductal papillary mucinous neoplasm of the pancreas: an emerging indication for surgical therapy.
[20524755] Rev Esp Enferm Dig 102(5): 293-5 (2010)
2010  
120
Intraductal papillary mucinous neoplasms (IPMN) of the pancreas: clinico-pathologic results.
[20524759] Rev Esp Enferm Dig 102(5): 314-20 (2010)
2009  
121
HuR modulates gemcitabine efficacy: new perspectives in pancreatic cancer treatment.
[19828005] Expert Rev Anticancer Ther 9(10): 1439-41 (2009)
2008  
122
Mechanism of in vitro pancreatic cancer cell growth inhibition by melanoma differentiation-associated gene-7/interleukin-24 and perillyl alcohol.
[18768668] Cancer Res 68(18): 7439-47 (2008)
2006  
123
Molecular target-based therapy of pancreatic cancer.
[16489047] Cancer Res 66(4): 2403-13 (2006)
2007  
124
Biology and management of pancreatic cancer.
[17625148] Gut 56(8): 1134-52 (2007)
2007  
125
Risk of pancreatic cancer in patients with cystic fibrosis.
[17698876] Gut 56(9): 1327-8 (2007)
2010  
126
2010  
127
Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markov-based clinical nomograms.
[19818780] Gastroenterology 138(2): 531-40 (2010)
2011  
128
The Smad family and its role in pancreatic cancer.
[21921337] Indian J Cancer 48(3): 351-60 (2011)
2009  
129
Pancreatic carcinogenesis: The impact of chronic pancreatitis and its clinical relevance.
[19749458] Indian J Cancer 46(4): 288-96 (2009)
2011  
130
A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma.
[21439076] J Hematol Oncol 4(-): 11 (2011)
2011  
131
Evolving diagnostic and treatment strategies for pancreatic neuroendocrine tumors.
[21672194] J Hematol Oncol 4(-): 29 (2011)
2009  
132
Epigenetics and epigenetic alterations in pancreatic cancer.
[19158989] Int J Clin Exp Pathol 2(4): 310-26 (2009)
2011  
133
Cystic tumors of the pancreas: a radiological perspective.
[20635318] Diagn Interv Radiol 17(2): 143-9 (2011)
2010  
134
PAR-4 as a possible new target for pancreatic cancer therapy.
[20426700] Expert Opin Ther Targets 14(6): 611-20 (2010)
2010  
135
Diagnosis of pancreatic tumors by endoscopic ultrasonography.
[21160578] World J Radiol 2(4): 122-34 (2010)
2011  
136
Differentiating pancreatic ductal adenocarcinoma from pancreatic serous cystadenoma, mucinous cystadenoma, and a pseudocyst with detailed analysis of cystic features on CT scans: a preliminary study.
[21430935] Korean J Radiol 12(2): 187-95 (2011)
2011  
137
Primary sarcoma of the pancreas, a rare histopathological entity. A case report with review of literature.
[21812970] World J Surg Oncol 9(-): 85 (2011)
2007  
138
Capecitabine: an evidence-based review of its effectiveness in the treatment of carcinoma of the pancreas.
[21221179] Core Evid 2(2): 111-9 (2007)
2004  
139
2010  
140
Giant cell tumor of the pancreas: a pathological diagnosis with poor prognosis.
[20688610] Hepatobiliary Pancreat Dis Int 9(4): 433-7 (2010)
2011  
141
Interventional endoscopic ultrasonography for pancreatic cancer.
[21603319] World J Clin Oncol 2(2): 108-14 (2011)
2010  
142
Current and Future Clinical Applications of High-Intensity Focused Ultrasound (HIFU) for Pancreatic Cancer.
[21103296] Gut Liver 4 Suppl 1(-): S57-61 (2010)
2010  
143
Granular cell tumor of the pancreas: A case report and review of literature.
[21160931] World J Gastrointest Oncol 2(2): 121-4 (2010)
2008  
144
2007  
145
2009  
146
Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis.
[19030927] World J Surg 33(4): 698-709 (2009)
2010  
147
Vacuolated cell pattern of pancreatobiliary adenocarcinoma: a clinicopathological analysis of 24 cases of a poorly recognized distinctive morphologic variant important in the differential diagnosis.
[20931225] Virchows Arch 457(6): 643-9 (2010)
2012  
148
Epidemiology, diagnosis, and management of cystic lesions of the pancreas.
[22007199] Gastroenterol Res Pract 2012(-): 147465 (2012)
2010  
149
Chemoprevention strategies for pancreatic cancer.
[20440279] Nat Rev Gastroenterol Hepatol 7(6): 347-56 (2010)
2010  
150
Biomarkers and molecular diagnosis of gastrointestinal and pancreatic neoplasms.
[20924366] Nat Rev Gastroenterol Hepatol 7(11): 620-8 (2010)
2009  
151
Pancreatic cancer: molecular pathogenesis and new therapeutic targets.
[19506583] Nat Rev Gastroenterol Hepatol 6(7): 412-22 (2009)
2011  
152
Cystic lymphangioma of the pancreas.
[22066114] J Korean Surg Soc 81(2): 141-5 (2011)
2010  
153
2008  
154
Biological approaches to therapy of pancreatic cancer.
[18724071] Pancreatology 8(4-5): 431-61 (2008)
2009  
155
High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma.
[19848064] Surgeon 7(5): 297-306 (2009)
2011  
156
Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable metastatic liver disease: a systematic review.
[21358176] Neuroendocrinology 93(4): 223-9 (2011)
2011  
157
From targets to treatments: a review of molecular targets in pancreatic neuroendocrine tumors.
[21893937] Neuroendocrinology 94(3): 177-90 (2011)
2011  
158
Screening for pancreatic cancer: what can cyst fluid analysis tell us?
[21399760] F1000 Med Rep 3(-): 3 (2011)
2009  
159
Monoclonal antibodies in the treatment of pancreatic cancer.
[20046965] Immunotherapy 1(2): 223-9 (2009)
2011  
160
Genetic and epigenetic alterations in pancreatic carcinogenesis.
[21886451] Curr Genomics 12(1): 15-24 (2011)
2011  
161
MicroRNA functional network in pancreatic cancer: from biology to biomarkers of disease.
[21799259] J Biosci 36(3): 481-91 (2011)
2007  
162
Pancreatic cancer: pathogenesis, prevention and treatment.
[17174370] Toxicol Appl Pharmacol 224(3): 326-36 (2007)
2009  
163
Skeletal metastases in pancreatic cancer: a retrospective study and review of the literature.
[19325940] Yale J Biol Med 82(1): 1-6 (2009)
2010  
164
The molecular targets for the diagnosis and treatment of pancreatic cancer.
[21253292] Gut Liver 4(4): 433-49 (2010)
2010  
165
Solid pseudopapillary tumor of the pancreas (SPPT). Still an unsolved enigma.
[21198316] Rev Esp Enferm Dig 102(12): 722-8 (2010)
2010  
166
Management of mucinous cystic neoplasms of the pancreas.
[21128317] World J Gastroenterol 16(45): 5682-92 (2010)
PMC   
167
Celiac plexus neurolysis in pancreatic cancer: the endoscopic ultrasound approach.
[24415863] World J Gastroenterol 20(1):110-7 (2014)
PMC   
168
Fiducial placement for stereotactic body radiation therapy under only endoscopic ultrasonography guidance in pancreatic and hepatic malignancy: practical feasibility and safety.
[24516706] Gut Liver 8(1):88-93 (2014)
PMC   
169
Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-kappaB and MMPs.
[23918941] J Cell Biol 202(3):563-77 (2013)
PMC   
170
Natural history of asymptomatic pancreatic cystic neoplasms.
[23374357] HPB (Oxford) 15(3):175-81 (2013)
PMC   
171
Systematic review of novel ablative methods in locally advanced pancreatic cancer.
[24605026] World J Gastroenterol 20(9):2267-78 (2014)
PMC   
172
Management of borderline and locally advanced pancreatic cancer: where do we stand?
[24605025] World J Gastroenterol 20(9):2255-66 (2014)
PMC   
173
Double bypass for inoperable pancreatic malignancy at laparotomy: postoperative complications and long-term outcome.
[23131226] Ann R Coll Surg Engl 94(8):563-8 (2012)
PMC   
174
Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN.
[24783207] Biomed Res Int 2014():474905 (2014)
PMC   
175
Acinar cell carcinoma: a rare pancreatic malignancy.
[24765506] Clin Pract 3(2):e18 (2013)
PMC   
176
Solid pancreatic masses: not always adenocarcinoma.
[24693277] Gastroenterol Hepatol (N Y) 8(12):853-4 (2012)
PMC   
177
En bloc vascular resection for the treatment of borderline resectable pancreatic head carcinoma.
[24772302] Mol Clin Oncol 2(3):369-374 (2014)
PMC   
178
Molecular markers for novel therapeutic strategies in pancreatic endocrine tumors.
[23211371] Pancreas 42(3):411-21 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Pancreas (Neoplasia).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Pancreas (Neoplasia).php on line 92